Inventor
BOITANO ANTHONY
US15 patents
⚠️ This page may combine multiple inventors who share the name “BOITANO ANTHONY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MAGENTA THERAPEUTICS INC
7 patentsUS10899843B2Jan 26, 2021
Compositions and methods for the depletion of CD117+ cells
MAGENTA THERAPEUTICS INC8 citations82
US10882915B2Jan 5, 2021
Compositions and methods for the depletion of CD117+ cells
MAGENTA THERAPEUTICS INC9 citations81
US10058573B1Aug 28, 2018
Dosing regimens for the mobilization of hematopoietic stem cells
MAGENTA THERAPEUTICS INC7 citations78
US11572411B2Feb 7, 2023
Anti-CD117 antibodies and conjugates
MAGENTA THERAPEUTICS INC2 citations68
US10576161B2Mar 3, 2020
Compositions and methods for the depletion of CD137+ cells
MAGENTA THERAPEUTICS INC1 citations58
US10434185B2Oct 8, 2019
Compositions and methods for the depletion of CD137+ cells
MAGENTA THERAPEUTICS INC1 citations58
US11260079B2Mar 1, 2022
Dosing regimens for the mobilization of hematopoietic stem and progenitor cells
MAGENTA THERAPEUTICS INC1 citations57
HEIDELBERG PHARMA RES GMBH
3 patentsUS12251448B2Mar 18, 2025
Compositions and methods for the depletion of CD5+ cells
HEIDELBERG PHARMA RES GMBH1 citations62
US12006370B2Jun 11, 2024
Use of anti-CD5 antibody drug conjugate (ADC) in allogeneic cell therapy
HEIDELBERG PHARMA RES GMBH0 citations61
US12403185B2Sep 2, 2025
Use of anti-CD137 antibody drug conjugate (ADC) in allogeneic cell therapy
HEIDELBERG PHARMA RES GMBH0 citations50
VOR BIOPHARMA INC
3 patentsUS12209135B2Jan 28, 2025
Anti-CD45 antibodies and conjugates thereof
VOR BIOPHARMA INC0 citations57
US12403200B2Sep 2, 2025
Methods and compositions for treating autoimmune diseases
VOR BIOPHARMA INC1 citations54
US12291576B2May 6, 2025
Anti-CD45 antibodies and conjugates thereof
VOR BIOPHARMA INC0 citations49